Skip to ContentSkip to Navigation
Over ons Praktische zaken Waar vindt u ons prof. dr. S. (Steven) de Jong

Publicaties

Everolimus decreases [U-13C]glucose utilization by pyruvate carboxylase in breast cancer cells in vitro and in vivo.

Genome-wide DNA methylation in relation to ARID1A deficiency in ovarian clear cell carcinoma

Independent transcriptional patterns reveal biological processes associated with disease-free survival in early colorectal cancer

Mechanisms underlying reversed TRAIL sensitivity in acquired bortezomib-resistant non-small cell lung cancer cells

RAD51 recruitment but not replication fork stability associates with PARP inhibitor response in ovarian cancer patient-derived xenograft models

Targeting tumour metabolism in melanoma to enhance response to immune checkpoint inhibition: A balancing act

Correction: Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

Glycogen synthase 1 targeting reveals a metabolic vulnerability in triple-negative breast cancer

NOTCH signaling limits the response of Low Grade Serous Ovarian Cancers to MEK inhibition

Pyruvate Dehydrogenase Kinase Inhibition by Dichloroacetate in Melanoma Cells Unveils Metabolic Vulnerabilities

Lees meer